{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:48:46Z","timestamp":1765295326419,"version":"3.37.3"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Amoxicillin is a broad-spectrum antibiotic used to treat a variety of gram-positive and gram-negative infections, such as infections of the ear, nose, and throat, genitourinary tract, skin, and lower respiratory tract; gonorrhea; and Helicobacter pylori. The prophylactic benefit of both amoxicillin and Augmentin (amoxicillin-clavulanate for use against \u03b2-lactamase\u2013expressing bacteria) was evaluated for inhalation anthrax in cynomolgus macaques in 2 studies. A pilot study on amoxicillin-clavulanate that used a portion of the study animals demonstrated empirically that dosing twice a day was efficacious. In a subsequent study on both amoxicillin and amoxicillin-clavulanate that used the remaining study animals, the animals were treated orally every 12 hours on days 1\u201328 postchallenge and followed for an additional 60 days (total of 88 days from day of aerosol challenge to when the animals were culled). The animals from each treatment arm of the 2 studies were completely protected. All untreated animals succumbed to the infection. The degree of protection observed in this study suggests that both amoxicillin and amoxicillin-clavulanate, administered prophylactically over a period of 28 days after a lethal exposure to Bacillus anthracis spores, is sufficient for full protection.<\/jats:p>","DOI":"10.1093\/cid\/ciac572","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T18:49:13Z","timestamp":1666032553000},"page":"S402-S410","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Amoxicillin and Amoxicillin-Clavulanate (Augmentin) for Antimicrobial Postexposure Prophylaxis Following <i>Bacillus anthracis<\/i> Inhalational Exposure in Cynomolgus Macaques"],"prefix":"10.1093","volume":"75","author":[{"given":"Raymond M","family":"Slay","sequence":"first","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham J","family":"Hatch","sequence":"additional","affiliation":[{"name":"Centre for Emergency Preparedness and Response, Public Health England , Porton Down, Wilton , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A","family":"Hewitt","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"first-page":"1","year":"2008","author":"Castle","key":"2022113009295836400_ciac572-B1"},{"key":"2022113009295836400_ciac572-B2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00003495-198122050-00001","article-title":"Amoxycillin\/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use","volume":"22","author":"Brogden","year":"1981","journal-title":"Drugs"},{"key":"2022113009295836400_ciac572-B3","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1128\/JCM.42.8.3626-3634.2004","article-title":"Mics of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest","volume":"42","author":"Turnbull","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2022113009295836400_ciac572-B4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"2022113009295836400_ciac572-B5"},{"key":"2022113009295836400_ciac572-B6","first-page":"175","article-title":"Efficacy testing of orally administered antibiotics against an inhalational Bacillus anthracis infection in BALB\/c mice","volume":"2","author":"Hatch","year":"2014","journal-title":"J Infect Dis Ther"},{"key":"2022113009295836400_ciac572-B7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.LAB.0000080599.43791.01","article-title":"Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis)","volume":"83","author":"Vasconcelos","year":"2003","journal-title":"Lab Invest"},{"key":"2022113009295836400_ciac572-B8","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1128\/JVI.03481-12","article-title":"Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques","volume":"87","author":"Hatch","year":"2013","journal-title":"J Virol"},{"key":"2022113009295836400_ciac572-B9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/1120009X.1990.11739013","article-title":"Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man","volume":"2","author":"Fraschini","year":"1990","journal-title":"J Chemother"},{"key":"2022113009295836400_ciac572-B10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/AAC.11.1.132","article-title":"Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration","volume":"11","author":"Spyker","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"2022113009295836400_ciac572-B11","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1128\/AAC.01376-15","article-title":"Efficacy of single and combined antibiotic treatments of anthrax in rabbits","volume":"59","author":"Weiss","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2022113009295836400_ciac572-B12","doi-asserted-by":"crossref","first-page":"e0228917","DOI":"10.1371\/journal.pone.0228917","article-title":"Using old antibiotics to treat ancient bacterium-\u03b2-lactams for Bacillus anthracis meningitis","volume":"15","author":"Sittner","year":"2020","journal-title":"PLoS One"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_3\/S402\/47443739\/ciac572.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_3\/S402\/47443739\/ciac572.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T14:52:03Z","timestamp":1669819923000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/Supplement_3\/S402\/6762173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":12,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2022,10,17]]},"published-print":{"date-parts":[[2022,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac572","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2022,10,15]]},"published":{"date-parts":[[2022,10,15]]}}}